Adeno-associated virus type 2 (AAV) is a human parvovirus which usually requires adenovirus or herpesvirus as a helper to replicate and is not pathogenic. In the absence of helper virus, AAV DNA integrates into the host genome with a strong preference for a region of chromosome 19. The AAV rep gene open reading frame encodes four overlapping Rep proteins. Rep68 and Rep78 bind specifically to the AAV genome's inverted terminal repeats (ITRs), have enzymatic activities which are necessary for the resolution of AAV hairpin termini into linear DNA, and regulate AAV gene expression. We have expressed wild-type and mutant Rep proteins from recombinant baculoviruses in insect cells, a rabbit reticulocyte transcription-translation system, or the HIV-1 long terminal repeat promoter in human 293 cell transient transfections. Several parts of the Rep coding region have been identified as being necessary for the various Rep functions. In particular, we have identified a domain within the amino-terminal portion of the Rep78 and Rep68 proteins which can direct binding to the AAV ITRs. We have also demonstrated the repression of AAV RNA levels by Rep proteins. We have identified a binding site for Rep proteins near the chromosome 19 integration site. This implies a role for Rep proteins in directed integration. Further study of this phenomenon may lead to the development of AAV-based gene therapy vectors with site-specific integration. We have developed a gene delivery system based on (AAV) for potential gene therapy of cystic fibrosis (CF). A truncated version of the cystic fibrosis transmembrane conductance regulator cDNA flanked by the AAV ITRs, which is efficiently packaged into AAV capsids, corrected the CF chloride channel defect in a tissue culture cell line derived from lung cells of a cystic fibrosis patient. We have also discovered a cryptic promoter within the AAV terminal repeats. Using the ITR promoters, larger genes than previously thought possible can be packaged into AAV vectors.

Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1993
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Xu, Xin; Zheng, Liwei; Yuan, Quan et al. (2018) Transforming growth factor-? in stem cells and tissue homeostasis. Bone Res 6:2
Bian, Qin; Jain, Amit; Xu, Xin et al. (2016) Excessive Activation of TGF? by Spinal Instability Causes Vertebral Endplate Sclerosis. Sci Rep 6:27093
Xie, Liang; Tintani, Francis; Wang, Xiao et al. (2016) Systemic neutralization of TGF-? attenuates osteoarthritis. Ann N Y Acad Sci 1376:53-64
Cui, Zhuang; Crane, Janet; Xie, Hui et al. (2016) Halofuginone attenuates osteoarthritis by inhibition of TGF-? activity and H-type vessel formation in subchondral bone. Ann Rheum Dis 75:1714-21
Qiu, Tao; Xian, Lingling; Crane, Janet et al. (2015) PTH receptor signaling in osteoblasts regulates endochondral vascularization in maintenance of postnatal growth plate. J Bone Miner Res 30:309-17
Xu, Xin; Zheng, Liwei; Bian, Qin et al. (2015) Aberrant Activation of TGF-? in Subchondral Bone at the Onset of Rheumatoid Arthritis Joint Destruction. J Bone Miner Res 30:2033-43
Crane, Janet L; Cao, Xu (2014) Bone marrow mesenchymal stem cells and TGF-? signaling in bone remodeling. J Clin Invest 124:466-72
Crane, Janet L; Zhao, Luo; Frye, Joseph S et al. (2013) IGF-1 Signaling is Essential for Differentiation of Mesenchymal Stem Cells for Peak Bone Mass. Bone Res 1:186-94
Zhen, Gehua; Wen, Chunyi; Jia, Xiaofeng et al. (2013) Inhibition of TGF-? signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19:704-12
Yu, Bing; Zhao, Xiaoli; Yang, Chaozhe et al. (2012) Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling. J Bone Miner Res 27:2001-14

Showing the most recent 10 out of 19 publications